Financial statements Bio Labs
Balance sheet data of BIO LABS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 257 409,30 | 257 342,69 | 2 827 514,71 | 2 481 409,79 | 2 374 496,10 | 2 333 874,10 |
| A. Fixed assets | 19 500,00 | 19 500,00 | 895 699,77 | 832 911,65 | 737 111,19 | 670 594,77 |
| B. Current assets | 237 909,30 | 237 842,69 | 1 931 814,94 | 1 648 498,14 | 1 637 384,91 | 1 663 279,33 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 257 409,30 | 257 342,69 | 2 827 514,71 | 2 481 409,79 | 2 374 496,10 | 2 333 874,10 |
| A. Equity | -89 790,00 | -90 889,51 | 2 175 364,90 | 2 027 400,94 | 1 920 698,04 | 1 872 995,04 |
| B. Liabilities and provisions for liabilities | 347 199,30 | 348 232,20 | 652 149,81 | 454 008,85 | 453 798,06 | 460 879,06 |
| I. Long-term liabilities | 95 000,00 | 95 000,00 | 95 000,00 | 95 000,00 | 95 000,00 | 95 000,00 |
| II. Short-term liabilities | 251 879,20 | 253 232,20 | 556 829,71 | 358 688,75 | 358 477,96 | 365 558,96 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.